| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1010776903 |
| P356 | DOI | 10.2165/00003088-199732050-00001 |
| P698 | PubMed publication ID | 9160169 |
| P2093 | author name string | Urquhart J | |
| P2860 | cites work | Prediction of diltiazem plasma concentration curves from limited measurements using compliance data | Q30978272 |
| Progestin-only oral contraception: a comprehensive review | Q33607170 | ||
| Compliance with topical timolol treatment | Q34191428 | ||
| Compliance and adverse drug reactions: a prospective study with ethinylestradiol using continuous compliance monitoring | Q34352990 | ||
| How often is medication taken as prescribed? A novel assessment technique | Q34525872 | ||
| Electronic compliance assessment of antifungal prophylaxis for human immunodeficiency virus-infected women. | Q35124752 | ||
| Pharmacists' interventions using an electronic medication-event monitoring device's adherence data versus pill counts | Q36768369 | ||
| Facilitated analysis of data on drug regimen compliance | Q36876464 | ||
| A 17-year-old mother seeking contraception | Q37884311 | ||
| Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications | Q38563152 | ||
| Beta-adrenergic blocker withdrawal syndromes in hypertension and other cardiovascular diseases | Q39469154 | ||
| Experimental reactivation of subsiding rheumatic fever | Q40318627 | ||
| A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure | Q40416536 | ||
| Microelectronic systems for monitoring and enhancing patient compliance with medication regimens | Q40541268 | ||
| Intention-to-treat analysis and the goals of clinical trials | Q40575057 | ||
| Role of patient compliance in clinical pharmacokinetics. A review of recent research | Q40648530 | ||
| Compliance with contraceptives and other treatments | Q41073804 | ||
| Telephone care as a substitute for routine clinic follow-up | Q41113642 | ||
| Improved compliance measures: applications in an ambulatory hypertensive drug trial | Q43471818 | ||
| The effect of medication compliance on the control of hypertension | Q44409080 | ||
| Dynamics of drug regimen compliance--its assessment by microprocessor-based monitoring | Q44543109 | ||
| Antihypertensive medication-taking. Investigation of a simple regimen | Q46222171 | ||
| Assessment of sulfonylurea adherence and metabolic control. | Q51591782 | ||
| Time to stop counting the tablets? | Q52876428 | ||
| [Behavior of patients with mild-to-moderate arterial hypertension in relation to their treatment. Contribution of an electronic pillbox] | Q53999051 | ||
| If Migraine Prophylaxis Does Not Work, Think About Compliance | Q54020643 | ||
| The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening. | Q54039405 | ||
| Compliance with anti-tuberculous therapy: a field trial of a pill-box with a concealed electronic recording device. | Q54129840 | ||
| Clinical use of the Medication Event Monitoring System: a new window into pediatric compliance. | Q64936445 | ||
| Adrenergic hypersensitivity after beta-blocker withdrawal in hypertrophic cardiomyopathy | Q67973243 | ||
| A nebulizer chronolog to monitor compliance with inhaler use | Q68058625 | ||
| The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers | Q68083941 | ||
| Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants | Q68147427 | ||
| Comparison of the digoxin marker with capsule counting and compliance questionnaire methods for measuring compliance to medication in a clinical trial | Q68219191 | ||
| On white-coat effects and the electronic monitoring of compliance | Q68851265 | ||
| Noncompliance in organ transplant recipients | Q69494312 | ||
| Compliance with topical pilocarpine treatment | Q69504359 | ||
| Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy? | Q69504360 | ||
| Compliance in clinical trials of two nonbronchodilator, antiasthma medications | Q70138089 | ||
| The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease | Q70309305 | ||
| A miniature compliance monitor for eyedrop medication | Q70386947 | ||
| Comparison of withdrawal phenomena after propranolol, metoprolol, and pindolol | Q70419745 | ||
| Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring | Q70736037 | ||
| Methods in assessing drug compliance | Q70947411 | ||
| Compliance monitoring of NSAID drug therapy in ankylosing spondylitis, experiences with an electronic monitoring device | Q71066061 | ||
| Dose Frequency and Dose Interval Compliance with Multiple Antiepileptic Medications During a Controlled Clinical Trial | Q71813622 | ||
| The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis | Q72319787 | ||
| Patterns of drug compliance with medications to be taken once and twice daily assessed by continuous electronic monitoring in primary care | Q72406156 | ||
| Patient compliance with once-daily and twice-daily oral formulations of 5-isosorbide mononitrate: a comparative study | Q72572817 | ||
| Actual versus prescribed timing of lovastatin doses assessed by electronic compliance monitoring | Q72693292 | ||
| A Study Design for Comparing the Effects of Missing Daily Doses of Antihypertensive Drugs | Q77614292 | ||
| P433 | issue | 5 | |
| P921 | main subject | pharmacotherapy | Q701216 |
| P304 | page(s) | 345-356 | |
| P577 | publication date | 1997-05-01 | |
| P1433 | published in | Clinical Pharmacokinetics | Q5133788 |
| P1476 | title | The electronic medication event monitor. Lessons for pharmacotherapy | |
| P478 | volume | 32 |
| Q34318474 | 6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study |
| Q38882371 | A framework for quantifying the influence of adherence and dose individualization |
| Q34481350 | Accounting for noncompliance in pharmacoeconomic evaluations |
| Q36541223 | Adherence in dermatology: a review of the last 20 years. |
| Q92001959 | Adherence in psychiatry |
| Q36475160 | Adherence to antihypertensive medications: is prescribing the right pill enough? |
| Q36416703 | Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: results from the IN-RANGE study |
| Q34457384 | Adverse events, compliance, and changes in therapy |
| Q33874739 | Anthropological approach of adherence factors for antihypertensive drugs. |
| Q34433880 | Antidepressant dosage taken by patients with bipolar disorder: factors associated with irregularity |
| Q35850210 | Approach to antihypertensive adherence: a feasibility study on the use of student health coaches for uninsured hypertensive adults |
| Q42640275 | Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild-to-moderate hypertension |
| Q36958657 | Association between adherence measurements of metoprolol and health care utilization in older patients with heart failure |
| Q37698067 | Barriers to and determinants of medication adherence among hypertensive patients attended National Health Service Hospital, Sunderland |
| Q93501289 | Cardiovascular medication: improving adherence |
| Q35781829 | Cardiovascular medication: improving adherence using prompting mechanisms |
| Q33868361 | Cardiovascular medication: improving adherence. |
| Q46979150 | Clinical evaluation of IDAS II, a new electronic device enabling drug adherence monitoring. |
| Q43961653 | Commentary on "A Framework for Quantifying the Influence of Adherence and Dose Individualization". |
| Q43892208 | Comparison of self-report and electronic monitoring of 6MP intake in childhood ALL: a Children's Oncology Group study |
| Q33652896 | Compliance assessment of ambulatory Alzheimer patients to aid therapeutic decisions by healthcare professionals |
| Q33697752 | Compliance with antihypertensive therapy |
| Q41718360 | Compliance with antihypertensive treatment: implications for practice |
| Q46906669 | Compliance-guided therapy : a new insight into the potential role of clinical pharmacologists |
| Q53202985 | Cost effectiveness of an adherence-improving programme in hypertensive patients. |
| Q73839656 | Defining the margins for errors in patient compliance with prescribed drug regimens |
| Q45156829 | Determining the feasibility of objective adherence measurement with blister packaging smart technology |
| Q36920114 | Development and validation of an instrument to assess treatment adherence for each individual drug taken by a patient |
| Q39159377 | Do travelers really take their mefloquine malaria chemoprophylaxis? Estimation of adherence by an electronic pillbox |
| Q38395019 | Economic evaluation of a behavior-modifying intervention to enhance antiepileptic drug adherence. |
| Q28345973 | Effect of patient education on adherence to drug treatment for rheumatoid arthritis: a randomised controlled trial |
| Q35999686 | Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review. |
| Q36950780 | Electronic monitoring of oral therapies in ethnically diverse and economically disadvantaged patients with rheumatoid arthritis: consequences of low adherence |
| Q38419360 | Empowering pharmacists in asthma management through interactive SMS (EmPhAsIS): study protocol for a randomized controlled trial |
| Q43563629 | Estimating the power of compliance-improving methods |
| Q36909131 | Extended-release formulations for the treatment of epilepsy |
| Q82523224 | How Dutch Orthoptists Deal with Noncompliance with Occlusion Therapy for Amblyopia |
| Q34109300 | INTERNAL MEDICINE IN THE 21ST CENTURY: Controlled drug delivery: therapeutic and pharmacological aspects |
| Q39064765 | Impact of disease, drug and patient adherence on the effectiveness of antiviral therapy in pediatric HIV. |
| Q39105190 | Improving Medication Adherence in Cardiometabolic Disease: Practical and Regulatory Implications |
| Q33722619 | Integrated approaches to management of hypertension: promoting treatment acceptance |
| Q36916785 | Integrated pharmacokinetics and pharmacodynamics in drug development |
| Q93145415 | Integration of Pharmacometrics and Pharmacoeconomics to Quantify the Value of Improved Forgiveness to Nonadherence: A Case Study of Novel Xanthine Oxidase Inhibitors for Gout |
| Q24246621 | Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings |
| Q33937236 | Measuring behavior: electronic devices in nursing studies |
| Q46073827 | Measuring therapeutic adherence in systemic lupus erythematosus with electronic monitoring |
| Q36341606 | Modeling and simulation of adherence: approaches and applications in therapeutics |
| Q45230929 | Non-adherence to cardiovascular medications |
| Q36695870 | Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children's oncology group |
| Q34403660 | Patient adherence to prescribed antimicrobial drug dosing regimens |
| Q40671674 | Patient- and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherence |
| Q34374899 | Persistent Lyme Empiric Antibiotic Study Europe (PLEASE)--design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis |
| Q73850406 | Pharmacodynamics of variable patient compliance: implications for pharmaceutical value |
| Q33761083 | Pharmacoeconomic consequences of variable patient compliance with prescribed drug regimens |
| Q39958352 | Pharmacokinetically based estimation of patient compliance with oral anticancer chemotherapies: in silico evaluation |
| Q35846675 | Pharmacokinetics, food intake requirements and tolerability of once-daily combinations of nelfinavir and low-dose ritonavir in healthy volunteers |
| Q52598467 | Posttraumatic stress disorder and nonadherence to medications prescribed for chronic medical conditions: A meta-analysis. |
| Q51953931 | Psychiatric morbidity and adherence to antiretroviral medication in patients with HIV/AIDS. |
| Q39559341 | Quantification of the Forgiveness of Drugs to Imperfect Adherence |
| Q50674664 | Relationship Between Adherence Rate Threshold and Drug 'Forgiveness'. |
| Q33439579 | Smartphone medication adherence apps: potential benefits to patients and providers |
| Q34457377 | Some economic consequences of noncompliance |
| Q47646260 | The Role of Minimally Invasive Glaucoma Surgery Devices in the Management of Glaucoma |
| Q77891660 | The impact of compliance on drug development |
| Q43008793 | The importance of social ties in sustaining medication adherence in resource-limited settings |
| Q39352816 | The logistic transform for bounded outcome scores |
| Q35803939 | The odds of the three nons when an aptly prescribed medicine isn't working: non-compliance, non-absorption, non-response |
| Q37608912 | The role of the affective temperament in the treatment adherence in psychiatry |
| Q34042008 | The utility of an electronic adherence assessment device in type 2 diabetes mellitus: a pilot study of single medication |
| Q38740848 | Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer's disease. |
| Q48122081 | Urinalysis of MMX-mesalazine as a tool to monitor 5-ASA adherence in daily IBD practice. |
| Q45024455 | Use of computer simulations to test the concept of dose forgiveness in the era of extended-release (XR) drugs |
| Q52941109 | Using inverse weighting and predictive inference to estimate the effects of time-varying treatments on the discrete-time hazard. |
| Q57774231 | When Drugs Don??t Work |
| Q86761117 | [Less can be more - drug therapy in the elderly] |
Search more.